Projection of Revenue Growth:
The Liquid Biopsy Market was valued at US$ 2.55 Bn. in 2023. Global Liquid Biopsy Market size is expected to grow at a CAGR of 20.9 % through the forecast period.
Liquid Biopsy Market Overview:
The comprehensive market analysis investigates the dynamic competitive landscape, offering crucial insights into market share data and detailed profiles of leading global companies. Through an in-depth examination of the Liquid Biopsy Market, the study identifies the key factors driving regional disparities in industry growth.
Details insights on this market, request for methodology here:https://www.maximizemarketresearch.com/request-sample/3261/
Liquid Biopsy Market Scope:
Following the market valuation phase, extensive primary research was conducted to gather, analyze, and verify essential data. This process included evaluating market size, forecasting future trends, identifying key factors, and ensuring data accuracy through triangulation. By employing both top-down and bottom-up approaches and additional verification methods, we thoroughly examined market segments and sub-segments. The data collected underwent rigorous qualitative and quantitative analysis, ensuring that the report provides in-depth insights.
Liquid Biopsy Market Regional Insights
The detailed regional analysis in Liquid Biopsy market research identifies key drivers and highlights regulatory changes impacting current and future market trends. By analyzing both existing and emerging patterns, the research reveals hidden market potential and identifies valuable opportunities for improving market positioning. This evaluation, considering both current conditions and future developments, offers a thorough understanding of the dynamics within various geographic markets.
Liquid Biopsy Market Segmentation
by Product
Assay Kits
Instruments
by Technology
Multi-gene-parallel Analysis (NGS)
Single Gene Analysis (PCR Microarrays)
by Application
Cancer
Non- Cancer
by End User
Reference Lab
Hospitals
Liquid Biopsy Market Key Players
1. F. Hoffmann-La Roche Ltd. (Switzerland)
2. Myriad Genetics, Inc. (US)
3. QIAGEN N.V. (Netherlands)
4. Thermo Fisher Scientific, Inc. (US)
5. Guardant Health, Inc. (US)
6. MDxHealth SA (Belgium)
7. Exact Sciences Corporation (US)
8. Illumina Inc. (US)
9. Sysmex Inostics (US)
10. Bio-Rad Laboratories, Inc. (US)
11. Biocept, Inc. (US)
12. NeoGenomics, Inc. (US)
13. ANGLE plc. (UK)
14. Menarini-Silicon Biosystems (Italy)
15. Vortex Biosciences, Inc. (US)
16. Exosome Diagnostics, Inc. (US)
17. Agena Bioscience, Inc. (US)
18. MedGenome Inc. (US)
19. Epigenomics AG (Germany)
20. Personal Genome Diagnostics, Inc. (US)
Please Contact Us On link:https://www.maximizemarketresearch.com/market-report/global-liquid-biopsy-market/3261/
Conclusion:
The global liquid biopsy market, valued at USD 2.55 billion in 2023, is projected to grow significantly to USD 9.63 billion by 2030, with a robust CAGR of 20.9%. This growth is driven by the increasing prevalence of cancer, the advantages of liquid biopsy over traditional methods, and technological advancements such as next-generation sequencing (NGS) and improved biomarker identification. Despite challenges like lower sensitivity and reimbursement uncertainties, the market's expansion is supported by rising cancer incidences, advancements in companion diagnostics, and the growing significance of exosomes and microvesicles in oncology. North America leads the market, benefiting from substantial investments and a supportive regulatory environment, while other regions also show promising growth potential.
Explore our top-performing reports on the latest trends:
Global Marine Drive System Market https://www.maximizemarketresearch.com/market-report/global-marine-drive-system-market/66988/
Asia Pacific HVAC Controls Market https://www.maximizemarketresearch.com/market-report/asia-pacific-hvac-controls-market/10556/
About Maximize Market Research:
Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.
Contact Maximize Market Research:
MAXIMIZE MARKET RESEARCH PVT. LTD.
⮝ 3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
✆ +91 9607365656
🖂 sales@maximizemarketresearch.com
🌐 www.maximizemarketresearch.com
